Traded Sep 15, 2025 · largest single transaction ~$62K
Show all 2 transactions
Sep 15, 2025~$62K · 6,500 sh @ $9.51
DetailsOfficial recordSep 15, 2025~$35K · 3,500 sh @ $9.94
DetailsOfficial record
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
AARD · NASDAQ · Pharmaceutical Preparations
Aardvark Therapeutics (AARD) · oqro.io/stocks/AARD · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$1.00+0.09 (+9.89%)
Close of Nov 19, 2026, vs Nov 18 · end-of-day
19 routine filings (option exercises, shares withheld for taxes, grants, gifts) are not listed here. Show them
Traded Sep 15, 2025 · largest single transaction ~$62K
Sep 15, 2025~$62K · 6,500 sh @ $9.51
DetailsOfficial recordSep 15, 2025~$35K · 3,500 sh @ $9.94
DetailsOfficial recordTraded Sep 10 – Sep 12, 2025 · largest single transaction ~$71K
Sep 10, 2025~$71K · 9,000 sh @ $7.91
DetailsOfficial recordInsider buying
Traded Sep 9, 2025 · filed 1 day later
Since the trade −88.3% · S&P 500 +6.1% · to Nov 20
The CFO of Aardvark Therapeutics paid $48K out of pocket for Aardvark Therapeutics shares. 1 other person at Aardvark Therapeutics bought some too, in the same month. It was the first purchase in 7 months.
Traded Feb 14, 2025 · largest single transaction ~$10M
Feb 14, 2025~$10M · 625K sh @ $16.00
DetailsOfficial recordInsider buying
Traded Feb 14, 2025 · filed 5 days later
Since the trade −93.1% · S&P 500 +13.1% · to Nov 20
The CFO of Aardvark Therapeutics paid $160K out of pocket for Aardvark Therapeutics shares. 3 other people at Aardvark Therapeutics bought some too, in the same month. Shares held went up 11% with this purchase.
Insider buying
Traded Feb 14, 2025 · filed 5 days later
Since the trade −93.1% · S&P 500 +13.1% · to Nov 20
Aardvark Therapeutics's LP, Reporting person paid $3M out of pocket for Aardvark Therapeutics shares. 3 other people at Aardvark Therapeutics bought some too, in the same month.
Insider buying
Traded Feb 14, 2025 · filed 5 days later
Since the trade −93.1% · S&P 500 +13.1% · to Nov 20
The CEO of Aardvark Therapeutics paid $265K out of pocket for Aardvark Therapeutics shares. 3 other people at Aardvark Therapeutics bought some too, in the same month.
Sep 11, 2025~$47K · 6,000 sh @ $7.82
DetailsOfficial recordSep 12, 2025~$43K · 5,000 sh @ $8.50
DetailsOfficial recordFeb 14, 2025~$10M · 625K sh @ $16.00
DetailsOfficial record0 open-market purchases and 2 open-market sales by insiders of AARD between Feb 21, 2026 and today, placed against the company's last 4 earnings releases. The latest on file was filed Nov 13, 2026.
PurchaseSale30 days before a release30 days after
| Earnings release | 30 days before | On the day | 30 days after |
|---|---|---|---|
| Nov 13, 2026 | None | None | None |
| Aug 11, 2026 | None | None | 1 sale |
| May 7, 2026 | None | None | None |
| Mar 23, 2026 | None | None | None |
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies